Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.
about
Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix lamininVaccinia virus A30L protein is required for association of viral membranes with dense viroplasm to form immature virions.Actions of the rifamycinsVaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infectionsIdentification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.A glutaredoxin, encoded by the G4L gene of vaccinia virus, is essential for virion morphogenesis.Regulation of vaccinia virus morphogenesis: phosphorylation of the A14L and A17L membrane proteins and C-terminal truncation of the A17L protein are dependent on the F10L kinase.DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane.Characterization of vaccinia virus intracellular cores: implications for viral uncoating and core structureThe vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.Vaccinia virus WR gene A5L is required for morphogenesis of mature virions.Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.Unique temperature-sensitive defect in vaccinia virus morphogenesis maps to a single nucleotide substitution in the A30L gene.The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components.Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusionsActivity, specificity, and probe design for the smallpox virus protease K7LVaccinia virus G1 protein, a predicted metalloprotease, is essential for morphogenesis of infectious virions but not for cleavage of major core proteins.Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis.An unconventional role for cytoplasmic disulfide bonds in vaccinia virus proteins.Analysis of vaccinia virus temperature-sensitive I7L mutants reveals two potential functional domainsVaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.Rifamycins: modulation of specific anti-poxviral activity by small substitutions on the piperazinyliminomethyl side chainSynthesis of vaccinia virus polypeptides in the presence of isatin-beta-thiosemicarbazone.Vaccinia virus A17L gene product is essential for an early step in virion morphogenesisVaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis.A vaccinia virus core protein, p39, is membrane associated.Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.Phosphoprotein component of vaccinia virions.Translation of mRNA from simian virus 40-infected cells into simian virus 40 capsid protein by cell-free extractsRegulation of synthesis of two immunologically distinct nucleic acid-dependent nucleoside triphosphate phosphohydrolases in vaccinia virus-infected HeLa cells.Effect of rifampin on the development of ribonucleic acid bacteriophage QSystem of double infection between vaccinia virus and mengovirus.Transient inhibition of polyoma virus synthesis by sendai virus (parainfluenza I). II. Mechanism of the interference by inactivated virusA transcriptionally controlled trans-processing assay: putative identification of a vaccinia virus-encoded proteinase which cleaves precursor protein P25K.trans processing of vaccinia virus core proteins.Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain.Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity.Orthopoxvirus gene expression in Xenopus laevis oocytes: a component of the virion is needed for late gene expression.
P2860
Q24336532-A5B891D7-EEAE-453B-BC39-3AB6A02D76F4Q24529142-D10BCAD6-8EE9-4B31-9933-E0B4099CA46DQ24618138-77BD040F-29D9-4520-B6B1-03BC30D55102Q28362129-1FD0C888-F68C-412A-BBBF-8D874C5F250BQ33271767-3F557F77-870E-4FF0-923F-1BD8E860D974Q33604728-4FE34BB0-816F-455D-A7B7-1749D9F664E9Q33645823-2F5F78A7-54C4-404F-BC78-36F7B4D13684Q33785603-BD313CF9-DA9B-4396-A3A9-919DF5C3E5E5Q33788819-1F73F044-DC31-4156-8844-D993D401D329Q33802038-54955F0D-9602-46A5-B178-14AF784FAC05Q33811821-970AA8A6-256B-4A23-B2D1-55944FF715C9Q33813478-7E8EEEBC-E33F-48AD-963C-42E296F85948Q33843207-20507509-5C26-4100-9607-3656BB2A88BBQ33849410-9CAEF263-9296-4F18-AF10-46A1B636956FQ34142767-02DF70A9-99BC-4ACF-BC65-9EF9A1F622E0Q34193623-2FE9A5C1-877E-4A61-AA1B-E084A215903BQ34355408-FA4D313E-2844-4384-8546-5DF9E3DEDDC2Q34421628-D9E894A7-988B-40E4-8AA2-1B0E402F5488Q34439162-F3E1E754-A0CF-43B7-9DDF-4D29D87670AAQ34553748-DEC84A39-62C7-422E-8E0A-BA6CF4CEC2D3Q34756523-609524FA-B6D3-497B-B7E8-22026677E817Q35039792-37EF1C1D-1D5D-4835-9049-F000351D3381Q35101363-7106943B-8C87-42B3-B90D-8BD35817F16CQ35642888-CCA36013-83BA-4C1F-B8B3-E99B68F25EDCQ35651160-1DD5BDA4-F4A7-44F5-A4A6-1813C7BA0489Q35844001-F721F14F-EC0D-4CB7-9FEC-81D9B298BC53Q35859887-04776F1C-7DE3-45C6-AAE3-B29D6F082C3AQ35870461-8C91BB8D-7A1C-4EB6-B3EA-A5B580CEABA5Q36540095-776FAA4E-E473-4D12-A88E-8A10D99EDE28Q36553369-EEF542F0-1D10-4E19-B9EE-062D0D605B51Q36557499-5F9366D4-60AA-4004-AFA0-7146CA9019F4Q36563931-CA435D65-2E39-46B3-99A0-E760B840AE26Q36581999-D0A952D6-140C-4D49-BCAA-E6C3614325B9Q36582034-061DFC58-BB56-4192-B591-C6670DC3C5A3Q36591534-0DC365D3-B2A1-479C-A22A-6FC3E850E3DAQ36637444-F77F9B3B-F70C-4330-9A75-473C9419105FQ36650283-DFA04971-E056-4312-9810-E6BADEEAFC76Q36650383-620E1415-DFB2-4361-883B-0F19558826B9Q36680349-947EC96D-9382-4E23-978C-DCA33B6E25B1Q36806002-46AE42F0-EF9A-4934-831F-2CB2120BBC45
P2860
Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.
description
1970 nî lūn-bûn
@nan
1970 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1970 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1970年の論文
@ja
1970年論文
@yue
1970年論文
@zh-hant
1970年論文
@zh-hk
1970年論文
@zh-mo
1970年論文
@zh-tw
1970年论文
@wuu
name
Formation of a vaccinia virus ...... sor: inhibition by rifampicin.
@ast
Formation of a vaccinia virus ...... sor: inhibition by rifampicin.
@en
type
label
Formation of a vaccinia virus ...... sor: inhibition by rifampicin.
@ast
Formation of a vaccinia virus ...... sor: inhibition by rifampicin.
@en
prefLabel
Formation of a vaccinia virus ...... sor: inhibition by rifampicin.
@ast
Formation of a vaccinia virus ...... sor: inhibition by rifampicin.
@en
P2860
P356
P1476
Formation of a vaccinia virus ...... sor: inhibition by rifampicin.
@en
P2860
P304
P356
10.1073/PNAS.66.3.677
P407
P577
1970-07-01T00:00:00Z